文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

口咽与肠道机会致病菌浓度与SARS-CoV-2危重症成人患者死亡独立相关

Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults.
PubMed 文献 · Crit Care · 2022-10-03
一句话结论单中心前瞻性队列显示,口咽/直肠拭子培养的肠球菌属、金黄色葡萄球菌和念珠菌属浓度每升高1个log,死亡风险增加≥17%,且独立于年龄、器官衰竭和抗生素治疗。

该单中心观察性前瞻性队列纳入2020年3月至9月收治的95例重症SARS-CoV-2感染危重症患者(765份样本),入院时及之后每周两次采集口咽和直肠拭子,定量培养机会致病菌并以16S rDNA测序评估肠道菌群。以第90天死亡为主要结局,第90天全因死亡率为44.2%(42/95)。将口咽和肠道机会致病菌浓度、肠道丰富度和多样性作为时间依赖协变量纳入多因素Cox模型,发现口咽和直肠的肠球菌属、金黄色葡萄球菌和念珠菌属浓度与更高的死亡风险相关,校正年龄、慢性病、每日抗菌药物使用和每日SOFA评分后关联仍显著;口咽或直肠拭子中肠球菌属、金黄色葡萄球菌和念珠菌属每升高1个log,死亡风险增加17%或以上。作者认为这为危重症SARS-CoV-2患者的预后提供了简单、廉价的基于菌群的标志物的前景。

要点

  • 第90天全因死亡率为44.2%(42/95),入院时SAPS 2为33[24;50]、SOFA评分为6[4;8]。
  • 口咽和直肠的肠球菌属、金黄色葡萄球菌和念珠菌属浓度与更高的死亡风险相关,校正年龄、慢性病、每日抗菌药物使用和每日SOFA评分后关联仍显著。
  • 口咽或直肠拭子中肠球菌属、金黄色葡萄球菌和念珠菌属每升高1个log,死亡风险增加17%或以上。
  • 研究为单中心观察性前瞻性队列,样本来自2020年3月至9月收治的95例重症SARS-CoV-2感染危重症患者(765份样本)。
  • 口咽和直肠拭子定量培养机会致病菌,肠道菌群组成以16S rDNA测序评估,机会致病菌浓度、肠道丰富度和多样性作为时间依赖协变量进入多因素Cox模型。

适用人群与场景

  • 重症SARS-CoV-2感染收治于ICU的危重症成人患者,来自单中心观察性前瞻性队列,2020年3月至9月纳入95例。

研究设计与关键结果

  • 研究类型为单中心观察性前瞻性队列,纳入95例重症SARS-CoV-2感染危重症患者,共765份样本,入院时及之后每周两次采集口咽和直肠拭子直至出院或死亡。
  • 入院时SAPS 2为33[24;50],SOFA评分为6[4;8];第90天全因死亡率为44.2%(42/95)。
  • 口咽和直肠的肠球菌属、金黄色葡萄球菌和念珠菌属浓度与更高的死亡风险相关,校正年龄、慢性病、每日抗菌药物使用和每日SOFA评分后关联仍显著。
  • 口咽或直肠拭子中肠球菌属、金黄色葡萄球菌和念珠菌属每升高1个log,死亡风险增加17%或以上。

证据类型、等级与局限

  • 证据类型:单中心观察性前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,经培养评估的口咽/肠道肠球菌属、金黄色葡萄球菌和念珠菌属浓度升高与死亡相关,独立于年龄、器官衰竭和抗生素治疗,为危重症SARS-CoV-2患者的预后提供了简单、廉价的基于菌群的标志物的前景。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The composition of the digestive microbiota may be associated with outcome and infections in patients admitted to the intensive care unit (ICU). The dominance by opportunistic pathogens (such as Enterococcus) has been associated with death. However, whether this association remains all throughout the hospitalization are lacking.

METHODS: We performed a single-center observational prospective cohort study in critically ill patients admitted with severe SARS-CoV-2 infection. Oropharyngeal and rectal swabs were collected at admission and then twice weekly until discharge or death. Quantitative cultures for opportunistic pathogens were performed on oropharyngeal and rectal swabs. The composition of the intestinal microbiota was assessed by 16S rDNA sequencing. Oropharyngeal and intestinal concentrations of opportunistic pathogens, intestinal richness and diversity were entered into a multivariable Cox model as time-dependent covariates. The primary outcome was death at day 90.

RESULTS: From March to September 2020, 95 patients (765 samples) were included. The Simplified Acute Physiology Score 2 (SAPS 2) at admission was 33 [24; 50] and a Sequential Organ Failure Assessment score (SOFA score) at 6 [4; 8]. Day 90 all-cause mortality was 44.2% (42/95). We observed that the oropharyngeal and rectal concentrations of Enterococcus spp., Staphylococcus aureus and Candida spp. were associated with a higher risk of death. This association remained significant after adjustment for prognostic covariates (age, chronic disease, daily antimicrobial agent use and daily SOFA score). A one-log increase in Enterococcus spp., S. aureus and Candida spp. in oropharyngeal or rectal swabs was associated with a 17% or greater increase in the risk of death.

CONCLUSION: We found that elevated oropharyngeal/intestinal Enterococcus spp. S. aureus and Candida spp. concentrations, assessed by culture, are associated with mortality, independent of age, organ failure, and antibiotic therapy, opening prospects for simple and inexpensive microbiota-based markers for the prognosis of critically ill SARS-CoV-2 patients.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Patrier J, Villageois-Tran K, Szychowiak P, et al. Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults. Crit Care. 2022. PMID: 36192756. doi:10.1186/s13054-022-04164-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。